All three of our Menstrual Equity priorities are on the move in the House!
10/16/25: Senate Unanimously Passes the I AM & Ingredient Disclosure Bills
On October 16, 2026, the Massachusetts Senate unanimously passed S.2641, An Act relative to menstrual product ingredient disclosure and S.2640, An Act to increase access to disposable menstrual products!
This is the third time the Massachusetts Senate has unanimously passed the I AM Bill, across four legislative sessions of advocacy — and the first time ever that the Ingredient Disclosure Bill has advanced this far. Menstrual equity is not only about making products free — it's about ensuring those products are safe, high quality, and labeled with full ingredient disclosure. We are deeply grateful that the Senate understands that dignity requires both access and accountability. Today's vote sends a powerful message: menstruators in Massachusetts deserve not just products, but the ability to make informed choices about what products they use for their menstrual health.
Please thank your Senator for voting in favor of these two bills!
10/20/25: MA House advances the I AM Bill and Ingredient Disclosure Bills
On October 20th, the House versions of the I AM Bill (now H.4611) and the Ingredient Disclosure Bill (now H.2375) were reported out of the Joint Committee on Public Health. H.2375, the Ingredient Disclosure Bill, was referred to the House Committee on Ways and Means, joining the Senate versions of the bill.
H.4611, the I AM Bill, was referred to the Health Care Financing Committee, alongside its Senate companion, S.2640. This redraft incorporates language from the former HB.3318 Public Buildings Bill, so - all three of our major priorities are on the move in the House now!
Now, we need your help to keep the momentum going! Please contact your State Representative and ask them to talk to Chair Michelwitz about bringing these important bills to a vote
What’s the difference between the bills?
The updated I AM bill (SB2546) keeps the same intent as SB1549—to provide free disposable menstrual products in schools, shelters, and correctional facilities—but clarifies language for consistency, adds that products must be in readily accessible locations, and changes phrasing to emphasize minimizing stigmatization rather than “convenient access.”
The updated Ingredient Disclosure bill (SB2641) keeps the core intent of SB1483—requiring ingredient disclosure for menstrual products—but makes the requirements more specific and flexible. It allows manufacturers 18 months to update product labels and 2 months to update online ingredient listings after any change, removes strict font-size rules, and clarifies that the fine is “not more than $1,000 per violation.”
H.4611, the I AM Bill, was referred to the Health Care Financing Committee. This redraft incorporates language from the former HB.3318 Public Buildings Bill, so - all three of our major priorities are on the move in the House now!
